Omega Diagnostics Group PLC Notice of Results (2991H)
July 27 2023 - 2:00AM
UK Regulatory
TIDMODX
RNS Number : 2991H
Omega Diagnostics Group PLC
27 July 2023
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Notice of Final Results
Investor Presentation
Omega (AIM: ODX), the specialist medical diagnostics company
focused on industry-leading Health & Nutrition products,
confirms it will issue its final results for the year ended 31
March 2023 on Thursday 3 August 2023.
Analyst briefing
A briefing for analysts will take place in London on Thursday 3
August 2023 at 9:30 BST. To register and for more details please
contact Walbrook PR on omega@walbrookpr.com .
Investor presentation
Jag Grewal, CEO and Chris Lea, CFO will provide a live
presentation relating to the Final Results via the Investor Meet
Company platform on Thursday 3 August 2023 at 16:30 BST.
The presentation is open to all existing and potential
shareholders. Questions can be submitted pre-event via your
Investor Meet Company dashboard up until 9am the day before the
meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add
to meet Omega Diagnostics Group plc via:
https://www.investormeetcompany.com/omega-diagnostics-group-plc/register-investor
Investors who already follow Omega Diagnostics Group plc on the
Investor Meet Company platform will automatically be invited.
Contacts:
Omega Diagnostics Group PLC www.omegadx.com
Jag Grewal, Chief Executive Officer via Walbrook PR
Chris Lea, Chief Financial Officer
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/Edward Whiley/George Dollemore
(Corporate Finance)
Alice Lane/Charlotte Sutcliffe (ECM)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com
Lianne Applegarth Mob: 07584 391 303
Sam Allen Mob: 07502 558 258
About Omega Diagnostics Group PLC
Omega (AIM: ODX) is a specialist medical diagnostics company
focused on promoting a personalised and functional approach to
health and nutrition.
www.omegadx.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORFZGZNZVGGFZM
(END) Dow Jones Newswires
July 27, 2023 02:00 ET (06:00 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Sep 2023 to Sep 2024